nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G7—blood plasma—abdominal aortic aneurysm	0.0604	0.181	CbGeAlD
Orlistat—PNLIP—blood plasma—abdominal aortic aneurysm	0.0531	0.159	CbGeAlD
Orlistat—FASN—SREBF and miR33 in cholesterol and lipid homeostasis—LDLR—abdominal aortic aneurysm	0.0443	0.0666	CbGpPWpGaD
Orlistat—PNLIP—Retinoid metabolism and transport—LRP1—abdominal aortic aneurysm	0.0389	0.0585	CbGpPWpGaD
Orlistat—DAGLB—kidney—abdominal aortic aneurysm	0.0339	0.101	CbGeAlD
Orlistat—PLA2G7—connective tissue—abdominal aortic aneurysm	0.0322	0.0962	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—CCL2—abdominal aortic aneurysm	0.0314	0.0472	CbGpPWpGaD
Orlistat—PNLIP—Retinoid metabolism and transport—LDLR—abdominal aortic aneurysm	0.0295	0.0443	CbGpPWpGaD
Orlistat—PNLIP—connective tissue—abdominal aortic aneurysm	0.0283	0.0846	CbGeAlD
Orlistat—PNLIP—Lipid and lipoprotein metabolism—LDLR—abdominal aortic aneurysm	0.0252	0.0378	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—MMP9—abdominal aortic aneurysm	0.0224	0.0337	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.0222	0.0334	CbGpPWpGaD
Orlistat—PLA2G4A—blood plasma—abdominal aortic aneurysm	0.0214	0.0641	CbGeAlD
Orlistat—PLA2G7—spinal cord—abdominal aortic aneurysm	0.0213	0.0638	CbGeAlD
Orlistat—ABHD16A—spinal cord—abdominal aortic aneurysm	0.02	0.0598	CbGeAlD
Orlistat—PNLIP—Diseases associated with visual transduction—LRP1—abdominal aortic aneurysm	0.0199	0.0299	CbGpPWpGaD
Orlistat—ABHD12—spinal cord—abdominal aortic aneurysm	0.0188	0.0561	CbGeAlD
Orlistat—FASN—spinal cord—abdominal aortic aneurysm	0.0157	0.0471	CbGeAlD
Orlistat—PNLIP—Retinoid metabolism and transport—APOE—abdominal aortic aneurysm	0.0153	0.023	CbGpPWpGaD
Orlistat—PNLIP—Diseases associated with visual transduction—LDLR—abdominal aortic aneurysm	0.0151	0.0226	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—AGT—abdominal aortic aneurysm	0.0139	0.0208	CbGpPWpGaD
Orlistat—PLA2G4A—Signal amplification—P2RY12—abdominal aortic aneurysm	0.0138	0.0208	CbGpPWpGaD
Orlistat—FASN—SREBP signalling—LDLR—abdominal aortic aneurysm	0.0138	0.0207	CbGpPWpGaD
Orlistat—PNLIP—Lipid and lipoprotein metabolism—APOE—abdominal aortic aneurysm	0.013	0.0196	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.0114	0.0172	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.0114	0.0172	CbGpPWpGaD
Orlistat—PLA2G4A—connective tissue—abdominal aortic aneurysm	0.0114	0.0341	CbGeAlD
Orlistat—DAGLB—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.00794	0.0119	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.00794	0.0119	CbGpPWpGaD
Orlistat—PNLIP—Diseases associated with visual transduction—APOE—abdominal aortic aneurysm	0.0078	0.0117	CbGpPWpGaD
Orlistat—PLA2G4A—spinal cord—abdominal aortic aneurysm	0.00757	0.0226	CbGeAlD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.0071	0.0107	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.0071	0.0107	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—abdominal aortic aneurysm	0.0071	0.0107	CbGpPWpGaD
Orlistat—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00707	0.0211	CbGeAlD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.00695	0.0104	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—SELL—abdominal aortic aneurysm	0.00654	0.00982	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—SELL—abdominal aortic aneurysm	0.00654	0.00982	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00633	0.00951	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.00633	0.00951	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00588	0.00884	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00588	0.00884	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.00572	0.0086	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00559	0.0084	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00559	0.0084	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00502	0.00754	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.005	0.00751	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.005	0.00751	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—abdominal aortic aneurysm	0.00491	0.00737	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—LRP1—abdominal aortic aneurysm	0.00484	0.00728	CbGpPWpGaD
Orlistat—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.00408	0.00613	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.00406	0.0061	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00376	0.00565	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00376	0.00565	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00372	0.00559	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00372	0.00559	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—abdominal aortic aneurysm	0.00361	0.00542	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.0036	0.0054	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.00338	0.00508	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00338	0.00507	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00338	0.00507	CbGpPWpGaD
Orlistat—CYP3A4—kidney—abdominal aortic aneurysm	0.00321	0.00958	CbGeAlD
Orlistat—PLA2G4A—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.00295	0.00444	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.00287	0.00432	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00271	0.00407	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.00262	0.00393	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet homeostasis—NOS2—abdominal aortic aneurysm	0.00258	0.00388	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00254	0.00382	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00253	0.00381	CbGpPWpGaD
Orlistat—PNLIP—Disease—LRP1—abdominal aortic aneurysm	0.00252	0.00379	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—NOS2—abdominal aortic aneurysm	0.0023	0.00346	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—NOS2—abdominal aortic aneurysm	0.0023	0.00346	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00226	0.0034	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00226	0.0034	CbGpPWpGaD
Orlistat—PNLIP—Disease—AAAS—abdominal aortic aneurysm	0.00219	0.00329	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.00215	0.00324	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00213	0.00321	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00213	0.00321	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00206	0.00309	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00206	0.00309	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.00205	0.00308	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—abdominal aortic aneurysm	0.00201	0.00302	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.002	0.003	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.002	0.003	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00194	0.00291	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00194	0.00291	CbGpPWpGaD
Orlistat—PNLIP—Disease—LDLR—abdominal aortic aneurysm	0.00191	0.00287	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.0019	0.00286	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.0019	0.00286	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.00188	0.00283	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00186	0.0028	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AAAS—abdominal aortic aneurysm	0.00183	0.00276	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00183	0.00275	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00183	0.00275	CbGpPWpGaD
Orlistat—PNLIP—Disease—NCF1—abdominal aortic aneurysm	0.00179	0.00269	CbGpPWpGaD
Orlistat—FASN—Disease—LRP1—abdominal aortic aneurysm	0.00179	0.00268	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00177	0.00266	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00165	0.00248	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SELL—abdominal aortic aneurysm	0.00164	0.00247	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00162	0.00243	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00162	0.00243	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—LDLR—abdominal aortic aneurysm	0.0016	0.00241	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00159	0.00239	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00159	0.00239	CbGpPWpGaD
Orlistat—FASN—Disease—AAAS—abdominal aortic aneurysm	0.00155	0.00233	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00151	0.00227	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00151	0.00227	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00148	0.00222	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00145	0.00217	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00145	0.00217	CbGpPWpGaD
Orlistat—FASN—Disease—LDLR—abdominal aortic aneurysm	0.00135	0.00203	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.00135	0.00202	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00134	0.00201	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00132	0.00198	CbGpPWpGaD
Orlistat—FASN—Metabolism—AAAS—abdominal aortic aneurysm	0.0013	0.00195	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.00128	0.00192	CbGpPWpGaD
Orlistat—FASN—Disease—NCF1—abdominal aortic aneurysm	0.00127	0.0019	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00125	0.00188	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00121	0.00182	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00121	0.00182	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00119	0.00179	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00119	0.00179	CbGpPWpGaD
Orlistat—FASN—Metabolism—LDLR—abdominal aortic aneurysm	0.00113	0.0017	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00109	0.00164	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00108	0.00163	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00108	0.00163	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00101	0.00151	CbGpPWpGaD
Orlistat—PNLIP—Disease—APOE—abdominal aortic aneurysm	0.000991	0.00149	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000946	0.00142	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000928	0.00139	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS2—abdominal aortic aneurysm	0.000923	0.00139	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000903	0.00136	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000897	0.00135	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000854	0.00128	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000854	0.00128	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00085	0.00128	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AGT—abdominal aortic aneurysm	0.000847	0.00127	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000837	0.00126	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000837	0.00126	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOE—abdominal aortic aneurysm	0.00083	0.00125	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000805	0.00121	CbGpPWpGaD
Orlistat—PNLIP—Disease—SERPINE1—abdominal aortic aneurysm	0.000777	0.00117	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000708	0.00106	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000704	0.00106	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000704	0.00106	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—abdominal aortic aneurysm	0.000701	0.00105	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000694	0.00104	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—abdominal aortic aneurysm	0.000679	0.00102	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000657	0.000987	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000657	0.000987	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—abdominal aortic aneurysm	0.000653	0.000981	CbGpPWpGaD
Orlistat—FASN—Metabolism—AGT—abdominal aortic aneurysm	0.000599	0.0009	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—abdominal aortic aneurysm	0.000587	0.000882	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000583	0.000876	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—abdominal aortic aneurysm	0.000579	0.00087	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000577	0.000867	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—abdominal aortic aneurysm	0.000568	0.000854	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000566	0.00085	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AAAS—abdominal aortic aneurysm	0.000557	0.000837	CbGpPWpGaD
Orlistat—FASN—Disease—SERPINE1—abdominal aortic aneurysm	0.00055	0.000826	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000544	0.000818	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000537	0.000806	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000517	0.000777	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000503	0.000756	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000503	0.000756	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000502	0.000754	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000498	0.000748	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000498	0.000748	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000487	0.000732	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LDLR—abdominal aortic aneurysm	0.000486	0.000731	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—abdominal aortic aneurysm	0.00048	0.000722	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000461	0.000693	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000417	0.000626	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000413	0.00062	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000407	0.000611	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—abdominal aortic aneurysm	0.000402	0.000604	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000388	0.000582	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00038	0.000572	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000364	0.000547	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000305	0.000459	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.0003	0.00045	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000272	0.000409	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AGT—abdominal aortic aneurysm	0.000257	0.000386	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—abdominal aortic aneurysm	0.000252	0.000378	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000215	0.000323	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000211	0.000316	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000177	0.000266	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—abdominal aortic aneurysm	0.000173	0.000259	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000165	0.000248	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.00013	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000127	0.00019	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000125	0.000188	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000114	0.000171	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	6.02e-05	9.05e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	5.9e-05	8.86e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	4.04e-05	6.07e-05	CbGpPWpGaD
